Want to see JP:3649 full AI Analyst Report?
3649 Stock Chart & Stats
¥824.00
-¥8.00(-0.93%)
At close: 4:00 PM EST
¥824.00
-¥8.00(-0.93%)
Day’s Range― - ―
52-Week Range¥717.00 - ¥1,011.00
Previous CloseN/A
Volume39.10K
Average Volume (3M)87.31K
Market Cap
¥22.69B
Enterprise Value¥16.68K
Total Cash (Recent Filing)¥2.47B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)19.3
Beta0.51
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.05%
Share Statistics
EPS (TTM)46.12
Shares Outstanding26,608,800
10 Day Avg. Volume79,900
30 Day Avg. Volume87,306
Financial Highlights & Ratios
PEG Ratio1.72
Price to Book (P/B)4.19
Price to Sales (P/S)3.73
P/FCF Ratio14.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)54.5
Revenue Forecast (FY)¥6.40B
Bulls Say, Bears Say
Bulls Say
High And Improving ProfitabilitySustained high margins (operating ~29%, net ~21% in 2025) and a multi-year expansion trend provide durable operating leverage. This supports recurring cash generation, funds for R&D/dividends, and resilience to cyclical revenue swings, strengthening long-term earnings quality.
Near-debt-free Balance SheetAn essentially debt-free capital structure materially lowers financial risk and interest burden, giving management flexibility to allocate capital to dividends, buybacks, or strategic investments. Strong ROE (~23%) indicates efficient use of equity while maintaining conservative leverage.
Strong Free Cash Flow ConversionFCF close to net income (~0.98x) shows solid earnings-to-cash conversion, supporting sustainable shareholder returns and reinvestment without reliance on external financing. Reliable cash generation underpins capital allocation and cushions against short-term revenue volatility.
Bears Say
Uneven Revenue GrowthInconsistent top-line history (periodic declines and flat years) complicates forecasting and strategic planning. Persistent uneven demand can stress capacity utilization and force margins to absorb revenue shortfalls, making sustained growth and long-term cash trajectory less predictable.
Operating Cash Flow VolatilityA meaningful year-over-year drop in operating cash flow and variable conversion across years signals working-capital swings or timing issues. If volatility persists it can constrain reinvestment or dividends despite solid FCF ratios, reducing financial resilience in stress scenarios.
Slight Equity Dip In 2025A decline in equity while earnings rose suggests capital returned to shareholders or balance-sheet adjustments; if recurring it erodes the capital base. A shrinking equity cushion can limit financial flexibility and elevate sensitivity to future losses or investment needs.
FINDEX Inc. News
3649 FAQ
What was FINDEX Inc.’s price range in the past 12 months?
FINDEX Inc. lowest stock price was ¥717.00 and its highest was ¥1011.00 in the past 12 months.
What is FINDEX Inc.’s market cap?
FINDEX Inc.’s market cap is ¥22.69B.
When is FINDEX Inc.’s upcoming earnings report date?
FINDEX Inc.’s upcoming earnings report date is Nov 18, 2026 which is in 54 days.
How were FINDEX Inc.’s earnings last quarter?
FINDEX Inc. released its earnings results on Aug 13, 2026. The company reported -¥0.11 earnings per share for the quarter.
Is FINDEX Inc. overvalued?
According to Wall Street analysts FINDEX Inc.’s price is currently Overvalued.
Does FINDEX Inc. pay dividends?
FINDEX Inc. pays a Semiannually dividend of ¥14 which represents an annual dividend yield of 3.05%. See more information on FINDEX Inc. dividends here
What is FINDEX Inc.’s EPS estimate?
FINDEX Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FINDEX Inc. have?
FINDEX Inc. has 26,608,800 shares outstanding.
What happened to FINDEX Inc.’s price movement after its last earnings report?
FINDEX Inc. reported an EPS of -¥0.11 in its last earnings report. Following the earnings report the stock price went up 1.13%.
Which hedge fund is a major shareholder of FINDEX Inc.?
Currently, no hedge funds are holding shares in JP:3649
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
FINDEX Inc.
FINDEX Inc., a company established in Tokyo in 1985, focuses on the creation, production, and distribution of medical technology systems across Japan. Their portfolio features Claio, a comprehensive medical imaging database management system utilized by hospitals of all sizes, and C-Note, a dedicated platform for managing patient progress notes. They also offer DocuMaker, a sophisticated document and data management solution engineered with various input tools to boost efficiency, and the GAP/GAP-screener, which is an advanced gaze analyzing perimeter. Additionally, FINDEX Inc. develops mobile applications for smartphones. Their services cater to a wide range of medical clients, including hospitals, clinics, and other healthcare institutions. The organization adopted its current name, FINDEX Inc., in November 2014, having previously operated as PSC Inc.